MARKET

ANAB

ANAB

Anaptysbio Inc
NASDAQ
64.55
+1.40
+2.22%
Opening 11:05 06/29 EDT
OPEN
63.48
PREV CLOSE
63.15
HIGH
64.56
LOW
61.93
VOLUME
128.60K
TURNOVER
--
52 WEEK HIGH
76.99
52 WEEK LOW
17.97
MARKET CAP
1.88B
P/E (TTM)
-73.5948
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ANAB last week (0622-0626)?
Weekly Report · 10h ago
AnaptysBio (ANAB) Draws Valuation Attention, Is The Market Already Pricing In Future Growth?
Simply Wall St · 4d ago
FedEx, Cerebras Systems And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
Benzinga · 5d ago
10 small-cap U.S. healthcare stocks with the strongest momentum grades
Seeking Alpha · 5d ago
AnaptysBio Subleases San Diego Facility to First Tracks
TipRanks · 6d ago
AnaptysBio subleases 45,057 sq ft San Diego office space to First Tracks Biotherapeutics
PUBT · 06/22 20:06
Weekly Report: what happened at ANAB last week (0615-0619)?
Weekly Report · 06/22 10:05
AnaptysBio (ANAB) Stock Could Be 84% Below Fair Value After Choppy Trading
Simply Wall St · 06/17 18:30
More
About ANAB
AnaptysBio, Inc. is a royalty management company. The Company manages the financial collaborations for Jemperli with GlaxoSmithKline (GSK) and imsidolimab with Vanda Pharmaceuticals Inc. (Vanda). The Company's financial collaboration with GSK is focused upon the development and commercialization of Anaptys-discovered Jemperli (dostarlimab), a PD-1 antagonist, approved for endometrial cancer and dMMR pan tumors, and is being studied in rectal cancer, colon cancer and head and neck squamous cell carcinoma. The Company's financial collaboration with Vanda is focused upon the development and commercialization of Anaptys-discovered imsidolimab, an IL-36R antagonist, which is being developed for generalized pustular psoriasis (GPP).

Webull offers AnaptysBio Inc stock information, including NASDAQ: ANAB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANAB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANAB stock methods without spending real money on the virtual paper trading platform.